ArticleScientific reports2021

Therapeutic effectiveness and safety of sintilimab-dominated triple therapy in unresectable hepatocellular carcinoma.

Lei Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.